TKT and lymphoma: Preliminary cytotoxicity tests indicated no significant cytotoxic effects of NRICM101 or 102 at doses of 1.25, 2.5, or 5.0 mg/mL in L5178Y/TK+/− mouse lymphoma cells (Figure 8; Supplementary Table S7).